Home › Therapeutic areas › Oncology › Large Cell Neuroendocrine Carcinoma
Large Cell Neuroendocrine Carcinoma (1 companies)
Companies with an active program in Large Cell Neuroendocrine Carcinoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| LEGN | Legend Biotech | Oncology Rare | 1 | Approved | $4.55B | 17 |
No companies match.